EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway

Jeanine M Roodhart, Marlies H Langenberg, Els Witteveen, Emile E Voest

Current Clinical Pharmacology · 01.05.2008 · 3 (2) · 132-143

DOI: 10.2174/157488408784293705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Clinical Pharmacology, erschienen am 01.05.2008. Verfasst von Jeanine M Roodhart und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology (F02.126), University Medical Center Utrecht, Utrecht, The Netherlands. Die Arbeit wurde bisher 179-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsAnimalsAntineoplastic AgentsBlood Coagulation DisordersHumansHypertensionHypothyroidismIntestinal PerforationNervous System DiseasesProteinuriaReceptors, Vascular Endothelial Growth FactorSignal TransductionVascular Endothelial Growth Factor A

Substanzen

Angiogenesis InhibitorsAntineoplastic AgentsVascular Endothelial Growth Factor AReceptors, Vascular Endothelial Growth Factor

Autor:innen und Institutionen

  • Department of Medical Oncology (F02.126), University Medical Center Utrecht, Utrecht, The Netherlands.

Zitieren

APA

Roodhart, J. M., Langenberg, M. H., Witteveen, E., & Voest, E. E. (2008). The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway. Current Clinical Pharmacology, 3(2), 132-143. https://doi.org/10.2174/157488408784293705

Vancouver

Roodhart JM, Langenberg MH, Witteveen E, Voest EE. The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway. Current Clinical Pharmacology. 2008;3(2):132-143. doi:10.2174/157488408784293705

BibTeX
@article{Roodhart2008,
  author = {Roodhart, Jeanine M and Langenberg, Marlies H and Witteveen, Els and Voest, Emile E},
  title = {The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway},
  journal = {Current Clinical Pharmacology},
  year = {2008},
  volume = {3},
  number = {2},
  pages = {132--143},
  doi = {10.2174/157488408784293705}
}
Kostenlos starten →